Peregrine Capital Management’s Cardiovascular Systems, Inc. CSII Stock Holding History

Peregrine Capital Management’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-355,728	Closed	-$15.2M	–	350
2021 Q2	$15.2M	Sell	355,728 -18,994	-5%	-$743K	0.27%	156
2021 Q1	$14.4M	Buy	374,722 +5,213	+1%	+$222K	0.27%	190
2020 Q4	$16.2M	Sell	369,509 -90,275	-20%	-$3.4M	0.31%	130
2020 Q3	$18.1M	Sell	459,784 -43,864	-9%	-$1.42M	0.48%	71
2020 Q2	$15.9M	Buy	503,648 +159,588	+46%	+$5.96M	0.45%	89
2020 Q1	$12.1M	Buy	+344,060	New	+$14.5M	0.43%	92

Other funds holding CSII

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Peregrine Capital Management's CSII Position: Q3 2021 in Review

Peregrine Capital Management sold out of Cardiovascular Systems, Inc. (CSII) in Q3 2021, closing a stake of 355,728 shares — an estimated $15.2M sold.

Peregrine Capital Management first reported a position in CSII in Q1 2020 and held it in 6 quarters. The position peaked at $18.1M in Q3 2020. 171 funds tracked by Wall St. Rank hold CSII as of Q3 2021.

Peregrine Capital Management reported no remaining Cardiovascular Systems, Inc. position as of Q3 2021 after selling out during the quarter.
Peregrine Capital Management sold 355,728 Cardiovascular Systems, Inc. shares in Q3 2021, an estimated $15.2M.
Peregrine Capital Management first reported a position in Cardiovascular Systems, Inc. in Q1 2020 and held it in 6 quarters.
Peregrine Capital Management's Cardiovascular Systems, Inc. position peaked at $18.1M in Q3 2020.
171 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q3 2021.

Based on Peregrine Capital Management's 13F filing for Q3 2021, filed 2 Nov 2021.